NCT00968227

Brief Summary

The purpose of this study is to determine if giving blood transfusions to anemic patients with subarachnoid hemorrhage will reduce their chances of having a stroke from vasospasm.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
56

participants targeted

Target at P50-P75 for phase_1

Timeline
Completed

Started Nov 2007

Longer than P75 for phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2007

Completed
1.8 years until next milestone

First Submitted

Initial submission to the registry

August 26, 2009

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 28, 2009

Completed
5.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2015

Completed
1.7 years until next milestone

Results Posted

Study results publicly available

April 17, 2017

Completed
Last Updated

April 17, 2017

Status Verified

March 1, 2017

Enrollment Period

7.8 years

First QC Date

August 26, 2009

Results QC Date

March 5, 2017

Last Update Submit

March 5, 2017

Conditions

Keywords

subarachnoid hemorrhagevasospasmtransfusioncerebral oxygen deliveryhemoglobin

Outcome Measures

Primary Outcomes (1)

  • Change in Oxygen Delivery in Vulnerable Brain Regions

    Change in oxygen delivery after transfusion in brain regions with low baseline delivery.

    1 hour

Secondary Outcomes (1)

  • Change in Oxygen Extraction Fraction in Regions With Low Baseline Delivery.

    1 hour

Study Arms (1)

Transfusion

EXPERIMENTAL
Biological: Red blood cell transfusion

Interventions

Transfusion of 1 unit of packed red blood cells over 1 hour.

Transfusion

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aneurysmal SAH confirmed by angiography
  • Hemoglobin \< 12.5 gm/dl
  • One of the following:
  • Considered at increased risk for vasospasm by care team
  • Angiographic vasospasm
  • Delayed ischemic deficit
  • Able to be studied within 2 weeks after subarachnoid hemorrhage

You may not qualify if:

  • Active Coronary Artery Disease
  • Severe congestive heart failure
  • Jehovah's witness
  • Unable to obtain appropriately matched blood
  • Other contraindications for transfusion
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Washington University Medical Center

St Louis, Missouri, 63110, United States

Location

Related Publications (1)

  • Dhar R, Zazulia AR, Videen TO, Zipfel GJ, Derdeyn CP, Diringer MN. Red blood cell transfusion increases cerebral oxygen delivery in anemic patients with subarachnoid hemorrhage. Stroke. 2009 Sep;40(9):3039-44. doi: 10.1161/STROKEAHA.109.556159. Epub 2009 Jul 23.

MeSH Terms

Conditions

Subarachnoid Hemorrhage

Interventions

Erythrocyte Transfusion

Condition Hierarchy (Ancestors)

Intracranial HemorrhagesCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesHemorrhagePathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Blood Component TransfusionBlood TransfusionBiological TherapyTherapeutics

Results Point of Contact

Title
Michael Diringer PI
Organization
Washington University

Study Officials

  • Michael Diringer, MD

    Washington University School of Medicine

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
phase 1
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 26, 2009

First Posted

August 28, 2009

Study Start

November 1, 2007

Primary Completion

August 1, 2015

Study Completion

August 1, 2015

Last Updated

April 17, 2017

Results First Posted

April 17, 2017

Record last verified: 2017-03

Locations